Tharimmune Corp (THAR) - Kapitalisasi pasar

The Tharimmune, Inc. (THAR) ecosystem develops advanced therapies for liver and skin lesions by implementing specific antibodies to alleviate chronic pruritus. The business currently relies on intensive R&D and clinical trials of new immunomodulators. Its technology stack is augmented by AI and robotics to accelerate the selection of anti-tumor compounds. Market capitalization stands at 0.19, as confirmed by the price evolution charts provided below.

THAR tharimmune.com: Nilai pasar ing interval 21.02.2024 - 18.02.2026

Rincian metrik lan analitis perusahaan Tharimmune Corporation (THAR)

Tharimmune, Inc. (THAR): dhaptar indikator lan metrik:

Rega saham Tharimmune|THAR - Konsensus nilai wajar|Kapitalisasi pasar Tharimmune Corporation

Pambiji fundamental perusahaan:Tharimmune THAR

Sampel barang Tharimmune, Inc.

The development progress of drugs by Tharimmune, Inc. (THAR) to combat autoimmune inflammation is directly reflected in the company's market capitalization. This indicator represents the aggregate market value of all the issuer's outstanding shares. The calculation is performed by multiplying the current quote by the total number of securities in circulation. For a biotech startup sustained by grants, this metric serves as a gauge of market confidence in future research. Growth in this metric confirms the capitalization of the business's intellectual potential.

Pesaing Tharimmune, Inc. (THAR)

Kapitalisasi pasar ONC (BeiGene)|Nilai pasar HALO|RevMed - Kapitalisasi pasar|AAPG - Kapitalisasi pasar|CG Oncology, Inc. (CGON) - Nilai pasar|urogen.com - Nilai pasar|BCAX (Bicara Therapeutics) - Kapitalisasi pasar|Biji pasar Personalis Inc (PSNL)|Kapitalisasi pasar ERAS|Kapitalisasi pasar Delcath Corp (DCTH)|Nilai pasar Y-mAbs Therapeutics YMAB|AURA: Kapitalisasi pasar|Candel - Kapitalisasi pasar|Accuray Inc (ARAY) - Biji pasar|SLS: Kapitalisasi pasar|Nilai pasar Actuate Therapeutics Inc (ACTU)|Nilai pasar Citius Oncology, Inc.|HURA: Nilai pasar|Biji pasar TARA (Protara Therapeutics, Inc.)|FATE (Fate Therapeutics Inc) - Nilai pasar|Kapitalisasi pasar WHWK (Aadi Bioscience)|TCRX - Biji pasar|CSBR: Biji pasar|XBIT - Kapitalisasi pasar|cel-sci.com (CVM) - Nilai pasar|OS Therapies Inc. - Nilai pasar|RADX (Radiopharm Theranostics) - Kapitalisasi pasar|Nilai pasar Artiva ARTV|Biji pasar ANL (Adlai Nortye Ltd.)|Nilai pasar VERU|Kapitalisasi pasar TPST (Tempest Therapeutics, Inc.)|Nilai pasar XLO|Enochian BioSciences - Kapitalisasi pasar|MURA - Kapitalisasi pasar|kairospharma.com (KAPA) - Nilai pasar|OnKure Therapeutics - Nilai pasar|GDTC (CytoMed Therapeutics Ltd) - Kapitalisasi pasar|Curis Corp (CRIS) - Kapitalisasi pasar|Nilai pasar Apollomics, Inc. (APLM)|Biji pasar advanbiomed.com ADVB|Nilai pasar Genprex, Inc. GNPX|CLDI - Biji pasar|SBFM: Biji pasar|XBIO - Kapitalisasi pasar|Salarius (SLRX) - Nilai pasar|Kapitalisasi pasar PPBT|AONC (American Oncology Network Inc) - Kapitalisasi pasar|Nilai pasar beigene.com BGNE|Biji pasar CKPT (Checkpoint Therapeutics, Inc.)|ELEV (Elevation Oncology Inc.) - Nilai pasar|Kapitalisasi pasar ICAD (iCAD)|Kapitalisasi pasar Ikena Oncology Inc. (IKNA)|NTBL - Nilai pasar|VIRX (Viracta Therapeutics) - Kapitalisasi pasar|MOR: Kapitalisasi pasar|Biji pasar NAYA Biosciences Inc|Biji pasar AAPGV